Company Search:
Advanced Search
Sponsored Links
Oxurion NV Company Snapshot
Oxurion NV operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oxurion NV with three other miscellaneous service companies in Europe: GW Pharmaceuticals PLC of the United Kingdom (2017 sales of £8.24 million [US$10.34 million] of which 94% was Commercial), Genoway of France (9.86 million Euro [US$11.12 million] ), and Midatech Pharma PLC which is based in the United Kingdom (£7.60 million [US$9.53 million] of which 88% was Commercial).

Sales Analysis. During the year ended December of 2017, sales at Oxurion NV were 9.06 million Euro (US$10.21 million). This is an increase of 27.5% versus 2016, when the company's sales were 7.10 million Euro. Despite this increase, sales are still well below the level achieved in 2015, when Oxurion NV reported sales of 11.20 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oxurion NV
  Stock Performance Chart for Oxurion NV
  Stock Data: Recent Stock Performance:
  Current Price (12/14/2018): 3.74
(Figures in Euro)
1 Week -0.3%   13 Weeks -10.7%  
4 Weeks -40.5%   52 Weeks 8.6%  
Oxurion NV Key Data:
  Ticker: OXUR Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2017 Sales 9,055,000
(Year Ending Jan 2018).
Employees: 74
  Currency: Euro Market Cap: 134,992,865
  Fiscal Yr Ends: December Shares Outstanding: 36,094,349
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 7,863,500
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.